"Unser Anspruch ist es, die Lebensqualität der Menschen zu verbessern, indem wir ihnen ein aktiveres, gesünderes und längeres Leben ermöglichen." So lautet das Mission Statement von GlaxoSmithKline (GSK), eines der heute weltweit führenden forschenden Pharmaunternehmen.

Welcome to GlaxoSmithKline

04.02.2010
GSK announces 2009 year-end financial results
GSK delivers 2009 EPS of 121.2p before major restructuring* and dividend of 61p (+4p) - Strategy supports return to sales growth (+3%) - Sustained R&D productivity; with further actions to improve returns
> mehr

15.01.2010
GlaxoSmithKline update: Government orders for pandemic H1N1 vaccine
Following declaration of the pandemic by the World Health Organization (WHO) in June 2009, GlaxoSmithKline (GSK) has been working closely with governments to respond to their changing needs as understanding of the H1N1 pandemic has increased.
> mehr

24.11.2009
Pandemic 2009 Influenza Update: Pandemrix™ data in children and adolescents from 3 to 17 years of age
GlaxoSmithKline (GSK) today announced that over 40 million doses of its adjuvanted pandemic H1N1 vaccine have been distributed to countries globally for use in government-initiated vaccination programmes.
> mehr



Unsere Informationen ersetzen den Besuch
eines Arztes nicht.

            © 2009 GlaxoSmithKline AG - All Rights Reserved
Talstrasse 3-5, 3053 Münchenbuchsee
Tel +41 31 862 21 11
Gültigkeit des shqa Vertrauenssiegel:
19. November 2011		 Nutzungs- und Datenschutzbestimmungen
Letzte Aktualisierung am: 04.02.2010